Navigating the Analytical Testing Bottleneck

This segment of the Outsourced Pharma Live event, "One Program Many CDMOs: Managing Multi-Partner Strategies," addresses the analytical bottlenecks that arise when testing methods are distributed across multiple geographic partners. The panelists recommend keeping analytical testing consolidated with a single CRO to avoid complex analytical bridging and maintain tighter control over release timelines. They also explore the value of building redundant testing networks to protect against delays and audit risks. Featuring panelists D.J. Harkins, Director, LVV Manufacturing and MS&T at Genetix, Laura Deschenes, PhD, Founder and Principal at Deschenes Consulting LLC, and Mark Davis, Founder & Principal at NegotiumBio.